Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-33.51%Return on Assets
VS
Market
Sector
Industry
History
$ 4.46Close
$ 2.07 - $ 7.08 52-Week Range
Ticker Information
Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQEVOKE PHARMA INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EVOK - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 16.06M | $ -5.38M | -33.51% |
| 3/31/2025 | $ 16.38M | $ -5.08M | -31.01% |
| 12/31/2024 | $ 17.52M | $ -5.35M | -30.55% |
| 9/30/2024 | $ 14.15M | $ -6.15M | -43.43% |
| 6/30/2024 | $ 12.14M | $ -6.53M | -53.79% |
| 3/31/2024 | $ 12.45M | $ -7.13M | -57.24% |
| 12/31/2023 | $ 7.07M | $ -7.79M | -110.24% |
| 9/30/2023 | $ 7.85M | $ -7.61M | -96.88% |
| 6/30/2023 | $ 8.98M | $ -7.93M | -88.29% |
| 3/31/2023 | $ 10.04M | $ -8.29M | -82.61% |
Key Performance Insights, Last 5 Years
- EVOKE PHARMA INC's latest trailing twelve months (TTM) ROA stands at -182.27%.
- Over the past 5 years, EVOKE PHARMA INC's average ROA has been -75.46%.
- The median ROA for EVOKE PHARMA INC during this period was -70.9%
- EVOKE PHARMA INC reached its highest ROA over the past 5 years at -30.55%.
- The lowest ROA recorded by EVOKE PHARMA INC in the same timeframe -182.27%
EVOKE PHARMA INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for EVOKE PHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -12.31M ] / Assets [ $ 6.75M ]
(=) ROA [ -182.27% ] EVOK - Return on Assets, Last 5 years
-182.27%
Minimum
Sep 30, 2020
-30.55%
Maximum
Dec 31, 2024
-75.46%
Average
-70.9%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.1% |
| median | 1.53% |
| std | 10.63% |